These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21531262)

  • 1. Initial combination therapy for treatment of hypertension.
    Chan SS; Rainer TH
    Lancet; 2011 Apr; 377(9776):1491; author reply 1492. PubMed ID: 21531262
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial combination therapy for treatment of hypertension.
    Ruggenenti P; Remuzzi G
    Lancet; 2011 Apr; 377(9776):1491; author reply 1492. PubMed ID: 21531263
    [No Abstract]   [Full Text] [Related]  

  • 3. Initial combination therapy for treatment of hypertension.
    Taranikanti V; Alriyami M; Banerjee Y
    Lancet; 2011 Apr; 377(9776):1490-1; author reply 1492. PubMed ID: 21531261
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of aliskiren/amlodipine combination and high-dose amlodipine monotherapy on endothelial function in elderly hypertensive patients.
    Fukutomi M; Hoshide S; Mizuno H; Kario K
    Am J Hypertens; 2014 Jan; 27(1):14-20. PubMed ID: 24008122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J; Ulmer HJ; Benduhn H; Klebs S
    Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y; Townsend R
    Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliskiren/amlodipine (Tekamlo): another combination tablet for hypertension.
    Med Lett Drugs Ther; 2010 Nov; 52(1352):94-5. PubMed ID: 21116232
    [No Abstract]   [Full Text] [Related]  

  • 8. Aliskiren for hypertension: just another option or something truly unique?
    Lee S
    S D Med; 2007 Oct; 60(10):405-6. PubMed ID: 18019776
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome.
    Weinberger MH; Izzo JL; Purkayastha D; Weitzman R; Black HR
    J Am Soc Hypertens; 2011; 5(6):489-97. PubMed ID: 21925996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
    Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
    J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
    Chrysant SG
    Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C; Sieder C; Meister F; Kaiser E
    Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with aliskiren and amlodipine in hypertension: treatment rationale and clinical results.
    Zion AS; Izzo JL
    Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):421-7. PubMed ID: 21417713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing Effects of Aliskiren/Amlodipine Combination and High-Dose Amlodipine Monotherapy on Ambulatory Blood Pressure and Target Organ Protection.
    Mizuno H; Hoshide S; Fukutomi M; Kario K
    J Clin Hypertens (Greenwich); 2016 Jan; 18(1):70-8. PubMed ID: 26176643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren-based dual- and triple-combination therapies in high-risk US minority patients with stage 2 hypertension.
    Ferdinand KC; Weitzman R; Purkayastha D; Sridharan K; Jaimes EA
    J Am Soc Hypertens; 2012; 6(3):219-27. PubMed ID: 22305998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study.
    Littlejohn TW; Jones SW; Zhang J; Hsu H; Keefe DL
    J Hum Hypertens; 2013 May; 27(5):321-7. PubMed ID: 23076450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aliskiren: a novel renin inhibitor for hypertension.
    Parmar DM; Jadav SP
    Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In brief: Another three-drug combination for hypertension.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):28. PubMed ID: 21464804
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Maffioli P; Monti C; Lazzari P; Mugellini A; Derosa G
    Diabetes Obes Metab; 2012 Apr; 14(4):341-7. PubMed ID: 22074122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.